CI Canadian Convertible Bond ETF Common (CXF) Competitors C$10.56 +0.01 (+0.09%) As of 08/29/2025 02:26 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendHeadlinesBuy This Stock CXF vs. IPA, APM, CRDL, GXE, MDNA, GPH, WMD, EQ, SGW, and CGCShould you be buying CI Canadian Convertible Bond ETF Common stock or one of its competitors? The main competitors of CI Canadian Convertible Bond ETF Common include ImmunoPrecise Antibodies (IPA), Andean Precious Metals (APM), Cardiol Therapeutics (CRDL), Gear Energy (GXE), Medicenna Therapeutics (MDNA), Graphite One (GPH), WeedMD (WMD), EQ (EQ), Shoal Games (SGW), and Canadian Gold (CGC). These companies are all part of the "pharmaceutical products" industry. CI Canadian Convertible Bond ETF Common vs. Its Competitors ImmunoPrecise Antibodies Andean Precious Metals Cardiol Therapeutics Gear Energy Medicenna Therapeutics Graphite One WeedMD EQ Shoal Games Canadian Gold ImmunoPrecise Antibodies (CVE:IPA) and CI Canadian Convertible Bond ETF Common (TSE:CXF) are both small-cap pharmaceutical products companies, but which is the superior business? We will compare the two businesses based on the strength of their media sentiment, risk, institutional ownership, analyst recommendations, dividends, valuation, earnings and profitability. Which has higher valuation and earnings, IPA or CXF? CI Canadian Convertible Bond ETF Common has lower revenue, but higher earnings than ImmunoPrecise Antibodies. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioImmunoPrecise AntibodiesC$19.47M8.33-C$22.19M-C$0.89-7.30CI Canadian Convertible Bond ETF CommonN/AN/AN/AN/AN/A Is IPA or CXF more profitable? Company Net Margins Return on Equity Return on Assets ImmunoPrecise AntibodiesN/A N/A N/A CI Canadian Convertible Bond ETF Common N/A N/A N/A Does the media prefer IPA or CXF? In the previous week, ImmunoPrecise Antibodies' average media sentiment score of 0.00 equaled CI Canadian Convertible Bond ETF Common'saverage media sentiment score. Company Overall Sentiment ImmunoPrecise Antibodies Neutral CI Canadian Convertible Bond ETF Common Neutral SummaryImmunoPrecise Antibodies beats CI Canadian Convertible Bond ETF Common on 1 of the 1 factors compared between the two stocks. Get CI Canadian Convertible Bond ETF Common News Delivered to You Automatically Sign up to receive the latest news and ratings for CXF and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CXF vs. The Competition Export to ExcelMetricCI Canadian Convertible Bond ETF CommonPharmaceutical Preparations IndustryManufacturing SectorTSE ExchangeMarket CapC$53.30MC$887.58MC$2.54BC$9.20BDividend Yield4.84%4.84%2.55%6.53%P/E RatioN/A1.1226.5524.76Price / SalesN/A26.93101.319.32Price / CashN/A19.5623.5183.29Price / BookN/A6.5532.225.34Net IncomeN/A-C$5.07MC$25.55MC$301.20M7 Day Performance2.42%0.71%0.46%2.87%1 Month Performance1.54%5.87%2.82%6.77%1 Year Performance8.53%19.64%26.01%32.25% CI Canadian Convertible Bond ETF Common Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CXFCI Canadian Convertible Bond ETF CommonN/AC$10.56+0.1%N/A+8.5%C$53.30MN/A0.0090Gap DownHigh Trading VolumeIPAImmunoPrecise AntibodiesN/AC$6.50+0.8%N/A+0.0%C$162.08MC$19.47M-7.3080Gap DownAPMAndean Precious Metals2.3648 of 5 starsC$1.29+7.5%C$2.00+55.0%+24.0%C$135.47MC$154.78M2.5530CRDLCardiol TherapeuticsN/AC$1.62flatN/A-42.9%C$134.43MN/A-3.1820GXEGear EnergyN/AN/AN/AN/AC$126.52MC$134.93M10.391,310MDNAMedicenna TherapeuticsN/AC$1.10-1.8%N/A-55.7%C$82.30MC$4.87K-3.0320GPHGraphite OneN/AC$0.81-4.7%N/A-7.6%C$82.02MN/A-11.6520News CoverageHigh Trading VolumeWMDWeedMDN/AC$0.28-1.8%N/A+0.0%C$67.82MC$27.53M-0.66628Gap UpEQEQN/AC$0.97flatN/A-11.8%C$67.51MC$9.70M-14.4840High Trading VolumeSGWShoal GamesN/AC$0.50+42.9%N/A+0.0%C$65.56MC$106.98K-12.5040Gap UpCGCCanadian GoldN/AC$0.32-0.6%N/A+103.0%C$58.94MC$36.51M-10.603,150News Coverage Related Companies and Tools Related Companies IPA Alternatives APM Alternatives CRDL Alternatives GXE Alternatives MDNA Alternatives GPH Alternatives WMD Alternatives EQ Alternatives SGW Alternatives CGC Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:CXF) was last updated on 8/31/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CI Canadian Convertible Bond ETF Common Please log in to your account or sign up in order to add this asset to your watchlist. Share CI Canadian Convertible Bond ETF Common With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
